BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 18, Issue 16
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3416)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.
Item 
Count 
PDF328
HTML2735
Figures (1-3)151
Tables (1-4)202
 Sum=3416
Apr 28, 2012 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Park H, Yoon JY, Park KH, Kim DY, Ahn SH, Han KH, Chon CY, Park JY. Hepatocellular carcinoma in Budd-Chiari syndrome: A single center experience with long-term follow-up in South Korea. World J Gastroenterol 2012; 18(16): 1946-1952 [PMID: 22563176 DOI: 10.3748/wjg.v18.i16.1946]
URL: https://www.wjgnet.com/1007-9327/full/v18/i16/1946.htm
Number Citing Articles
1
Andrea Mancuso. Budd–Chiari Syndrome Management: Controversies and Open Issues. Diagnostics 2022; 12(11): 2670 doi: 10.3390/diagnostics12112670
2
Xingshun Qi, Weirong Ren, Yongji Wang, Xiaozhong Guo, Daiming Fan. Survival and prognostic indicators of Budd–Chiari syndrome: a systematic review of 79 studies. Expert Review of Gastroenterology & Hepatology 2015; 9(6): 865 doi: 10.1586/17474124.2015.1024224
3
Dominique-Charles Valla. Budd–Chiari syndrome/hepatic venous outflow tract obstruction. Hepatology International 2018; 12(S1): 168 doi: 10.1007/s12072-017-9810-5
4
Chao Zhang, Yongquan Gu, Ce Bian, Guangchang Zhu, Tao Luo, Chao Yan, Zhonggao Wang. Hybrid Treatment for Budd–Chiari Syndrome: A Case Report by 11-Year Follow-up. Annals of Vascular Surgery 2017; 38: 319.e1 doi: 10.1016/j.avsg.2016.05.132
5
Andrea Mancuso. Focusing the Controversies in Budd-Chiari Syndrome Management. The International Journal of Gastroenterology and Hepatology Diseases 2022; 1(1) doi: 10.2174/2666290601666210406162525
6
Naomi Shin, Young H Kim, Hao Xu, Hai-Bin Shi, Qing-Qiao Zhang, Jean Paul Colon Pons, Ducksoo Kim, Yi Xu, Fei-Yun Wu, Samuel Han, Byung-Boong Lee, Lin-Sun Li. Redefining Budd-Chiari syndrome: A systematic review. World Journal of Hepatology 2016; 8(16): 691-702 doi: 10.4254/wjh.v8.i16.691
7
Kumble Seetharama Madhusudhan, Sanjay Sharma. Ultrasonography in pediatric Budd–Chiari syndrome. Pediatric Radiology 2020; 50(12): 1768 doi: 10.1007/s00247-020-04753-7
8
Marta Martín-Llahí, Agustín Albillos, Rafael Bañares, Annalisa Berzigotti, M. Ángeles García-Criado, Joan Genescà, Virginia Hernández-Gea, Elba Llop-Herrera, Helena Masnou-Ridaura, José Mateo, Carmen A. Navascués, Ángela Puente, Marta Romero-Gutiérrez, Macarena Simón-Talero, Luis Téllez, Fanny Turon, Cándido Villanueva, Roberto Zarrabeitia, Juan Carlos García-Pagán. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver. Gastroenterología y Hepatología (English Edition) 2017; 40(8): 538 doi: 10.1016/j.gastre.2017.03.014
9
Qiuhe Wang, Guohong Han. Diagnostic Methods for Cirrhosis and Portal Hypertension. 2018; : 257 doi: 10.1007/978-3-319-72628-1_17
10
Susana Seijo, Laurie D. DeLeve. Yamada' s Textbook of Gastroenterology. 2015; : 2171 doi: 10.1002/9781118512074.ch111
11
Kang-Shuai Li, Sen Guo, Yu-Xin Chen, Zong-Li Zhang. Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1075685
12
Anandini Suri, Varun K. Sharma, Prajakta R. Ranade, Shaji Marar, Aabha Nagral. Ruptured hepatocellular carcinoma in a child with Budd-Chiari syndrome. Indian Pediatrics 2016; 53(9): 833 doi: 10.1007/s13312-016-0941-x
13
Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Alimentary Pharmacology & Therapeutics 2015; 41(10): 961 doi: 10.1111/apt.13173
14
Laurie D. Deleve, Susana Seijo. Zakim and Boyer's Hepatology. 2018; : 649 doi: 10.1016/B978-0-323-37591-7.00044-6
15
Mohammad Sakr, Sara M. Abdelhakam, Hany Dabbous, Amr Hamed, Zeinab Hefny, Waleed Abdelmoaty, Mohamed Shaker, Mohamed El‐Gharib, Ahmed Eldorry. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd‐Chiari syndrome. Liver International 2017; 37(3): 415 doi: 10.1111/liv.13219
16
Dominique-Charles Valla. Portal Hypertension VI. 2016; : 397 doi: 10.1007/978-3-319-23018-4_39
17
Lamia Y.K. Haque, Joseph K. Lim. Budd-Chiari Syndrome. Clinics in Liver Disease 2020; 24(3): 453 doi: 10.1016/j.cld.2020.04.012
18
Diagnosis and treatment guidelines for aberrant portal hemodynamics. Hepatology Research 2017; 47(5): 373 doi: 10.1111/hepr.12862
19
Marta Martín-Llahí, Agustín Albillos, Rafael Bañares, Annalisa Berzigotti, M. Ángeles García-Criado, Joan Genescà, Virginia Hernández-Gea, Elba Llop-Herrera, Helena Masnou-Ridaura, José Mateo, Carmen A. Navascués, Ángela Puente, Marta Romero-Gutiérrez, Macarena Simón-Talero, Luis Téllez, Fanny Turon, Cándido Villanueva, Roberto Zarrabeitia, Juan Carlos García-Pagán. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017; 40(8): 538 doi: 10.1016/j.gastrohep.2017.03.011
20
Iván A. González, Dhanpat Jain. Diagnosis and classification of vascular liver disorders. Diagnostic Histopathology 2023; 29(1): 36 doi: 10.1016/j.mpdhp.2022.10.005
21
Jian-Ping Dou, Jie Yu, Zhi-yu Han, Fang-yi Liu, Zhi-gang Cheng, Ping Liang. Microwave ablation for hepatocellular carcinoma associated with Budd–Chiari syndrome after transarterial chemoembolization: an analysis of ten cases. Abdominal Radiology 2017; 42(3): 962 doi: 10.1007/s00261-016-0923-4
22
Ya-dong Wang, Huan-zhou Xue, Xiao Zhang, Zong-quan Xu, Qing-feng Jiang, Quan Shen, Miao Yu, Ke Li, Meng Jia. Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma. Chinese Medical Journal 2013; 126(19): 3632 doi: 10.3760/cma.j.issn.0366-6999.20130898
23
Akash Shukla, Ananta Shreshtha, Amar Mukund, Chhagan Bihari, C. E. Eapen, Guohong Han, Hemant Deshmukh, Ian Homer Y. Cua, Cosmas Rinaldi Adithya Lesmana, Mamun Al Meshtab, Masayoshi Kage, Roongruedee Chaiteeraki, Sombat Treeprasertsuk, Suprabhat Giri, Sundeep Punamiya, Valerie Paradis, Xingshun Qi, Yasuhiko Sugawara, Zaigham Abbas, Shiv Kumar Sarin. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatology International 2021; 15(3): 531 doi: 10.1007/s12072-021-10189-4
24
Ankit Agarwal, Sagnik Biswas, Shekhar Swaroop, Arnav Aggarwal, Ayush Agarwal, Gautam Jain, Anshuman Elhence, Arun Vaidya, Amit Gupte, Ravi Mohanka, Ramesh Kumar, Ashwani Kumar Mishra, Shivanand Gamanagatti, Shashi Bala Paul, Subrat Kumar Acharya, Akash Shukla, Shalimar. Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome. World Journal of Gastrointestinal Oncology 2024; 16(3): 699-715 doi: 10.4251/wjgo.v16.i3.699
25
Lionel Arrivé, Jessica Zucman‐Rossi, Pierre Balladur, Dominique Wendum. Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis. Hepatology 2016; 64(2): 675 doi: 10.1002/hep.28590
26
Nawel Afredj, Nabil Debzi. Budd-Chiari Syndrome. 2020; : 113 doi: 10.1007/978-981-32-9232-1_9
27
Alisha Chaubal, Akash Shukla. Budd-Chiari Syndrome. 2020; : 231 doi: 10.1007/978-981-32-9232-1_18
28
Juan Putra, Linda D. Ferrell, Annette S.H. Gouw, Valerie Paradis, Arvind Rishi, Christine Sempoux, Charles Balabaud, Swan N. Thung, Paulette Bioulac-Sage. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon. Modern Pathology 2020; 33(4): 665 doi: 10.1038/s41379-019-0374-x
29
Sheng-Yan Liu, Lu-Hao Li, Zhao-Chen Liu, Su-Xin Li, Xiao-Wei Dang. Development of a prognostic scoring system for hepatic vena cava Budd-Chiari syndrome with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2023;  doi: 10.1016/j.hbpd.2023.03.005
30
Andrea Mancuso. Budd-Chiari Syndrome. 2020; : 245 doi: 10.1007/978-981-32-9232-1_19
31
Debi Prasad, Mindie H. Nguyen. Epidemiology, pathogenesis, diagnosis, surveillance, and management of hepatocellular carcinoma associated with vascular liver disease. The Kaohsiung Journal of Medical Sciences 2021; 37(5): 355 doi: 10.1002/kjm2.12368
32
Dominique‐Charles Valla. Schiff's Diseases of the Liver. 2017; : 909 doi: 10.1002/9781119251316.ch33
33
Xixiang Gao, Zhu Tong, Lianrui Guo, Jianxin Li, Jian Zhang, Yongquan Gu. Angioplasty for Budd-Chiari Syndrome in a Child with 26-Year Follow-up. Annals of Vascular Surgery 2018; 51: 328.e7 doi: 10.1016/j.avsg.2018.03.004
34
Laure Elkrief, Dominique Valla. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 645 doi: 10.1002/9781119211419.ch42
35
Faisal Khan, Matthew J. Armstrong, Homoyon Mehrzad, Frederick Chen, Desley Neil, Rachel Brown, Owen Cain, Dhiraj Tripathi. Review article: a multidisciplinary approach to the diagnosis and management of Budd‐Chiari syndrome. Alimentary Pharmacology & Therapeutics 2019; 49(7): 840 doi: 10.1111/apt.15149
36
Qiuhe Wang, Guohong Han. Image-guided treatment of Budd-Chiari syndrome: a giant leap from the past, a small step towards the future. Abdominal Radiology 2018; 43(8): 1908 doi: 10.1007/s00261-017-1341-y
37
Satoko Ohfuji, Yoshihiro Furuichi, Tomohiko Akahoshi, Masayoshi Kage, Katsutoshi Obara, Makoto Hashizume, Tomoka Matsuura, Wakaba Fukushima, Yosikazu Nakamura. Japanese periodical nationwide epidemiologic survey of aberrant portal hemodynamics. Hepatology Research 2019; 49(8): 890 doi: 10.1111/hepr.13343
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345